Display options
Share it on

Front Oncol. 2017 Sep 14;7:216. doi: 10.3389/fonc.2017.00216. eCollection 2017.

Obesity and Cancer Metabolism: A Perspective on Interacting Tumor-Intrinsic and Extrinsic Factors.

Frontiers in oncology

Steven S Doerstling, Ciara H O'Flanagan, Stephen D Hursting

Affiliations

  1. Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  2. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  3. University of North Carolina Nutrition Research Institute, Kannapolis, NC, United States.

PMID: 28959684 PMCID: PMC5604081 DOI: 10.3389/fonc.2017.00216

Abstract

Obesity is associated with increased risk and poor prognosis of many types of cancers. Several obesity-related host factors involved in systemic metabolism can influence tumor initiation, progression, and/or response to therapy, and these have been implicated as key contributors to the complex effects of obesity on cancer incidence and outcomes. Such host factors include systemic metabolic regulators including insulin, insulin-like growth factor 1, adipokines, inflammation-related molecules, and steroid hormones, as well as the cellular and structural components of the tumor microenvironment, particularly adipose tissue. These secreted and structural host factors are extrinsic to, and interact with, the intrinsic metabolic characteristics of cancer cells to influence their growth and spread. This review will focus on the interplay of these tumor cell-intrinsic and extrinsic factors in the context of energy balance, with the objective of identifying new intervention targets for preventing obesity-associated cancer.

Keywords: autophagy; calorie restriction; cancer; cancer metabolism; growth factors; inflammation; obesity

References

  1. Cancer Discov. 2015 Oct;5(10):1024-39 - PubMed
  2. Br J Cancer. 2009 Feb 24;100(4):578-82 - PubMed
  3. Obes Rev. 2007 Jan;8(1):21-34 - PubMed
  4. Nat Rev Cancer. 2008 Jan;8(1):51-6 - PubMed
  5. Trends Biochem Sci. 2012 Aug;37(8):317-24 - PubMed
  6. Cancer Metab. 2013 Mar 07;1(1):10 - PubMed
  7. N Engl J Med. 2017 Jan 19;376(3):254-266 - PubMed
  8. Nat Rev Clin Oncol. 2012 Apr 03;9(5):259-67 - PubMed
  9. Cancer Res. 2014 Dec 15;74(24):7198-204 - PubMed
  10. Int J Cancer. 2017 Jul 1;141(1):102-111 - PubMed
  11. J Clin Oncol. 2009 Jul 10;27(20):3297-302 - PubMed
  12. Cell Cycle. 2015;14(16):2667-76 - PubMed
  13. Mol Cancer Res. 2008 Jul;6(7):1099-105 - PubMed
  14. J Biol Chem. 1995 Oct 6;270(40):23780-4 - PubMed
  15. Curr Opin Lipidol. 2009 Oct;20(5):379-85 - PubMed
  16. Cell. 2017 Feb 9;168(4):657-669 - PubMed
  17. J Endocrinol Invest. 2013 Apr;36(4):211-5 - PubMed
  18. J Clin Invest. 2000 Aug;106(4):473-81 - PubMed
  19. Breast Cancer Res Treat. 2013 Nov;142(1):119-32 - PubMed
  20. J Clin Endocrinol Metab. 2000 Sep;85(9):3338-42 - PubMed
  21. Nat Rev Cancer. 2011 Feb;11(2):85-95 - PubMed
  22. Ageing Res Rev. 2017 Oct;39:46-58 - PubMed
  23. J Clin Oncol. 2002 Jan 1;20(1):42-51 - PubMed
  24. J Nutr Biochem. 2008 Jun;19(6):371-5 - PubMed
  25. Nat Med. 2013 Jan;19(1):83-92 - PubMed
  26. J Natl Cancer Inst. 2005 Nov 16;97(22):1688-94 - PubMed
  27. Cancer Metab. 2016 Sep 16;4:18 - PubMed
  28. Neuron. 1999 Feb;22(2):221-32 - PubMed
  29. J Clin Med. 2014 Dec 22;3(4):1561-74 - PubMed
  30. Diabetes Care. 2006 Jun;29(6):1337-44 - PubMed
  31. Nat Rev Cancer. 2012 Feb 16;12(3):159-69 - PubMed
  32. Semin Cancer Biol. 2009 Feb;19(1):25-31 - PubMed
  33. Lancet Oncol. 2010 Jun;11(6):530-42 - PubMed
  34. Angiogenesis. 2008;11(1):101-6 - PubMed
  35. Nat Rev Drug Discov. 2016 Sep;15(9):639-60 - PubMed
  36. Trends Endocrinol Metab. 2012 Aug;23(8):407-15 - PubMed
  37. Lancet. 2011 Jan 1;377(9759):31-41 - PubMed
  38. Ann Oncol. 2016 Dec;27(12 ):2184-2195 - PubMed
  39. Nat Med. 2011 Oct 30;17(11):1498-503 - PubMed
  40. Nat Immunol. 2011 Jul 19;12(8):715-23 - PubMed
  41. Biomed Res Int. 2015;2015:274585 - PubMed
  42. Int J Cancer. 2010 Apr 1;126(7):1702-15 - PubMed
  43. PLoS One. 2013 Jun 27;8(6):e67349 - PubMed
  44. Cell Death Dis. 2017 Feb 2;8(2):e2593 - PubMed
  45. Int J Cancer. 2013 May 1;132(9):1977-85 - PubMed
  46. Int J Endocrinol. 2013;2013:678159 - PubMed
  47. Br J Cancer. 2006 May 8;94(9):1221-5 - PubMed
  48. Aging (Albany NY). 2010 Nov;2(11):823-42 - PubMed
  49. Nat Rev Cancer. 2010 Mar;10(3):181-93 - PubMed
  50. EMBO J. 2004 Jul 21;23 (14 ):2830-40 - PubMed
  51. Tumour Biol. 2016 Sep;37(9):11553-11572 - PubMed
  52. Ann Oncol. 2012 Jul;23(7):1771-80 - PubMed
  53. Nat Rev Endocrinol. 2014 Aug;10 (8):455-465 - PubMed
  54. Cancer Prev Res (Phila). 2010 Nov;3(11):1451-61 - PubMed
  55. Cell Metab. 2017 May 2;25(5):1037-1043 - PubMed
  56. Endocrinology. 2011 Jul;152(7):2546-51 - PubMed
  57. Cell. 2011 Mar 4;144(5):646-74 - PubMed
  58. J Clin Oncol. 2010 Sep 10;28(26):4058-65 - PubMed
  59. Clin Cancer Res. 2015 Nov 15;21(22):5037-46 - PubMed
  60. J Clin Invest. 2003 Dec;112(12):1821-30 - PubMed
  61. J Clin Endocrinol Metab. 2007 Apr;92(4):1510-6 - PubMed
  62. Cancer Prev Res (Phila). 2013 Apr;6(4):282-9 - PubMed
  63. Cancer Prev Res (Phila). 2016 May;9(5):339-48 - PubMed
  64. Nat Rev Mol Cell Biol. 2014 Mar;15(3):155-62 - PubMed
  65. Clin Cancer Res. 2004 Jul 1;10(13):4325-31 - PubMed
  66. JAMA. 2006 Apr 5;295(13):1539-48 - PubMed
  67. Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6659-63 - PubMed
  68. Endocr Relat Cancer. 2007 Sep;14(3):669-77 - PubMed
  69. Nat Rev Cancer. 2014 May;14(5):329-41 - PubMed
  70. Brain Pathol. 2010 Mar;20(2):481-9 - PubMed
  71. Nat Rev Clin Oncol. 2017 Jan;14 (1):11-31 - PubMed
  72. Cancer Res. 2014 Aug 15;74(16):4446-57 - PubMed
  73. Mol Cell Biol. 2007 Nov;27(21):7381-93 - PubMed
  74. Cell Metab. 2016 Jan 12;23 (1):27-47 - PubMed
  75. Cytokine Growth Factor Rev. 2010 Feb;21(1):11-9 - PubMed
  76. Clin Chim Acta. 2017 May;468:85-89 - PubMed
  77. N Engl J Med. 2000 Jun 29;342(26):1946-52 - PubMed
  78. J Cell Physiol. 2006 Apr;207(1):12-22 - PubMed
  79. Oxid Med Cell Longev. 2013;2013:972913 - PubMed
  80. Lancet. 2012 Apr 28;379(9826):1591-601 - PubMed
  81. Cancer Res. 2008 Jan 1;68(1):323-8 - PubMed
  82. J Biol Chem. 2015 Jul 10;290(28):17495-504 - PubMed
  83. Cancers (Basel). 2014 Jul 31;6(3):1579-96 - PubMed
  84. J Clin Invest. 2003 Dec;112(12):1796-808 - PubMed
  85. Front Oncol. 2013 Apr 25;3:96 - PubMed
  86. Endocr Relat Cancer. 2012 Feb 13;19(1):57-68 - PubMed
  87. Biomed Res Int. 2014;2014:658913 - PubMed
  88. Trends Endocrinol Metab. 2006 Oct;17(8):328-36 - PubMed
  89. Mol Cell Biol. 2002 Oct;22(20):7004-14 - PubMed
  90. Cancer Cell. 2016 Jul 11;30(1):147-160 - PubMed
  91. Carcinogenesis. 2010 Jan;31(1):83-9 - PubMed
  92. PLoS One. 2008 Jul 16;3(7):e2722 - PubMed
  93. Eur J Cancer. 2011 Jan;47(1):33-43 - PubMed
  94. Cancer Metab. 2017 Jan 13;5:1 - PubMed
  95. Int J Cancer. 2014 Jun 1;134(11):2683-90 - PubMed
  96. Cancer Res. 2004 Jun 1;64(11):3892-9 - PubMed
  97. Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7265-70 - PubMed
  98. Oncogene. 2006 Oct 30;25(51):6817-30 - PubMed
  99. Cancer Cell. 2007 Jul;12(1):9-22 - PubMed
  100. Biochimie. 2016 Jun;125:259-66 - PubMed
  101. Cell Death Dis. 2010;1:e10 - PubMed
  102. Trends Mol Med. 2014 Aug;20(8):419-27 - PubMed
  103. IUBMB Life. 2017 Jul;69(7):510-521 - PubMed
  104. Lancet. 2012 Apr 28;379(9826):1602-12 - PubMed
  105. Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1333-40 - PubMed
  106. Sci Adv. 2016 May 27;2(5):e1600200 - PubMed
  107. Oncogene. 2014 Mar 27;33(13):1670-9 - PubMed
  108. Br J Cancer. 2006 Feb 27;94(4):455-9 - PubMed
  109. J Gastroenterol Hepatol. 2012 Mar;27 Suppl 2:10-4 - PubMed
  110. Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):84-91 - PubMed
  111. Cell Metab. 2014 Mar 4;19(3):407-17 - PubMed
  112. Science. 2009 May 22;324(5930):1029-33 - PubMed
  113. Science. 2013 Mar 29;339(6127):1546-58 - PubMed
  114. Trends Mol Med. 2008 Mar;14(3):109-19 - PubMed
  115. Front Physiol. 2013 Oct 02;4:275 - PubMed
  116. J Clin Endocrinol Metab. 2005 Apr;90(4):2244-9 - PubMed
  117. Nature. 2010 Jan 21;463(7279):364-8 - PubMed
  118. Curr Opin Genet Dev. 2010 Feb;20(1):51-6 - PubMed
  119. Int J Cancer. 2004 Mar;109(1):149-52 - PubMed
  120. Nature. 2009 Apr 9;458(7239):725-31 - PubMed
  121. Mol Carcinog. 2013 Jun;52(6):446-58 - PubMed
  122. J Biol Chem. 2007 Jul 13;282(28):20534-43 - PubMed
  123. Cancer Discov. 2016 Dec;6(12 ):1315-1333 - PubMed
  124. Biochim Biophys Acta. 2014 Dec;1846(2):617-29 - PubMed
  125. Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2413-8 - PubMed
  126. Int J Cancer. 2003 Feb 20;103(5):642-6 - PubMed
  127. Nat Rev Cancer. 2007 Oct;7(10):763-77 - PubMed
  128. Endocrinology. 2007 Jun;148(6):2994-3003 - PubMed
  129. Ann Hum Biol. 2011 Mar;38(2):194-202 - PubMed
  130. Autophagy. 2017 Mar 4;13(3):567-578 - PubMed
  131. Am J Epidemiol. 2017 Jan 15;185(2):86-95 - PubMed
  132. Expert Opin Ther Targets. 2015 Apr;19(4):527-38 - PubMed
  133. Acta Diabetol. 2014 Feb;51(1):91-101 - PubMed
  134. J Biol Chem. 2014 Sep 5;289(36):25382-92 - PubMed
  135. Cancer Biol Med. 2016 Mar;13(1):101-19 - PubMed
  136. Mol Cell Endocrinol. 1991 Aug;79(1-3):C147-52 - PubMed
  137. J Nippon Med Sch. 2010 Apr;77(2):97-105 - PubMed
  138. Cell Cycle. 2008 Aug;7(15):2392-400 - PubMed
  139. Nat Cell Biol. 2008 May;10 (5):611-8 - PubMed

Publication Types

Grant support